Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal passage is a complex physiological process representing the transit of luminal contents, including food, liquids, and pharmacological agents, through the digestive tract. This movement is governed by the coordinated neuro-muscular contractions of the smooth muscle layers, known as peristalsis, which are regulated by the enteric nervous system and the autonomic nervous system (Source: StatPearls, Gastrointestinal Motility). While it is not a specific molecular target like a protein or receptor, the rate of gastrointestinal passage is a critical pharmacokinetic determinant that influences the bioavailability and absorption of orally administered drugs (Source: PubMed, PMID: 11155981). Pathological alterations in this process can lead to significant clinical conditions, including gastroparesis, chronic idiopathic constipation, and diarrhea (Source: NIH/NIDDK). Pharmacological interventions often seek to modulate this passage by targeting specific receptors, such as serotonin 5-HT4 receptors to accelerate transit or mu-opioid receptors to slow it down (Source: PubChem). Monitoring transit time is essential for diagnosing functional gastrointestinal disorders and evaluating the efficacy of prokinetic or antidiarrheal therapies. Ultimately, maintaining a normal gastrointestinal passage is vital for nutrient homeostasis and the predictable performance of oral medications.
Modulation of gastrointestinal motility via the activation or inhibition of enteric receptors, such as 5-HT4 serotonin receptors, D2 dopamine receptors, or mu-opioid receptors, to alter peristaltic speed (Source: StatPearls).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal passage (GI passage).